| 中文名 | 扎维格帕Vazegant (Zavegant,BHV-3500) |
|---|---|
| 英文名 | N-{(2R)-3-(7-Methyl-1H-indazol-5-yl)-1-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]-1-oxo-2-propanyl}-4-(2-oxo-1,2-dihydro-3-quinolinyl)-1-piperidinecarboxamide |
| 中文别名 |
(R)-N-(3-(7-甲基-1H-吲唑-5-基)-1-(4-(1-甲基哌啶-4-基)哌嗪-1-基)-1-氧代丙-2-基)-4-(2-氧代-1,2-二氢喹啉-3-基)哌啶-1-甲酰胺
4-(1,2-二氢-2-氧代-3-喹啉基)-N-[(1R)-1-[(7-甲基-1H-吲唑-5-基)甲基]-2-[4-(1-甲基-4-哌啶基)-1-哌嗪基]-2-氧代乙基]-1-哌啶甲酰胺 扎维格帕 扎维吉泮 |
| 英文别名 |
1-Piperidinecboxamide, 4-(1,2-dihydro-2-oxo-3-quinolinyl)-N-[(1R)-1-[(7-methyl-1H-indazol-5-yl)methyl]-2-[4-(1-methyl-4-piperidinyl)-1-piperazinyl]-2-oxoethyl]
Vazegant (R)-N-(3-(7-Methyl-1H-indazol-5-yl)-1-(4-(1-methylpiperidin-4-yl)piperazin-1-yl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-cboxamide N-[(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-1H-quinolin-3-yl)piperidine-1-cboxamide Zavegant (Vazegant Zavegant (BHV-3500, BMS-742413) Zevagant Zavegant Vazegant free base N-[(2R)-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-1,2-dihydroquinolin-3-yl)piperidine-1-cboxamide BHV-3500 BMS 742413) |
| 描述 | Vazegepant是第一种用于偏头痛急性研究的鼻内CGRP受体拮抗剂[1][2]。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 沸点 | 933.7±65.0 °C at 760 mmHg |
| 分子式 | C36H46N8O3 |
| 分子量 | 638.80 |
| 闪点 | 518.5±34.3 °C |
| 精确质量 | 638.369263 |
| LogP | 4.30 |
| 蒸汽压 | 0.0±0.3 mmHg at 25°C |
| 折射率 | 1.648 |